Eiger Biopharmaceuticals Inc's Suppliers Performance

Name: Eiger Biopharmaceuticals Inc 's (EIGR) Suppliers by Company, Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

EIGR's Supply Chain

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


EIGR Costs vs Sales of Suppliers Growth		Eiger Biopharmaceuticals Inc's cost of sales deteriorated by -39.42 % year on year, sequentially cost of sales grew by 81.74 % in Q4. • More on EIGR Suppliers

Eiger Biopharmaceuticals Inc's cost of sales deteriorated by -39.42 % year on year, sequentially cost of sales grew by 81.74 % in Q4.

• More on EIGR Suppliers

Select the Relationship:

Suppliers ▼

Select the Category:

Comparison ▼

Suppliers ▼

Basic Report▼

Eiger Biopharmaceuticals Inc's Comment on Supply Chain

The company utilizes contract manufacturers (CMOs) for the production of Zokinvy and Jitixib (lonafarnib). Merck manufactured the drug product for completed lonafarnib Phase 2 clinical studies. Technology transfer for lonafarnib drug substance and product manufacturing to third-party manufacturers has been completed; these manufacturers will supply future HDV clinical trials and commercial supply for HGPS. For the lambda program, technology transfer from BMS to the company's contract development and manufacturing organizations (CDMOs) has been completed, with sufficient inventory obtained under the license agreement to complete Phase 2 and initiate Phase 3 trials. Additional batches of lambda have been manufactured, demonstrating equivalence to BMS materials. Avexitide clinical trial materials are produced by third-party CDMOs. All lonafarnib and lambda products from CDMOs are manufactured in compliance with Good Manufacturing Practice (GMP) standards.

Eiger Biopharmaceuticals Inc's Comment on Supply Chain

EIGR's Stock Perfrormance relative to it's Suppliers

EIGR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Eiger Biopharmaceuticals Inc	2.55	15.77	-74.96	60
SUBTOTAL	0.00	0.00	0.00	-

Sources: Eiger Biopharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 4:23 PM
For your research, we’ve provided nine additional tables on Eiger Biopharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.